Gapping up
In reaction to earnings/guidance: DD +6.3%, (issues guidance; Chair and CEO of DuPont, announced that she will retire from the company effective October 16), MNK +5.8%, SIMO +3.7%, PEP +2.6%
M&A news: PMCS +32.6% (PMC-Sierra to be acquired by Skyworks (SWKS) for $10.50 per share), STRZA +7.2% (LA Times reporting co and Lions Gate Entertainment (LGF) are in advanced merger talks), SBGL +5.5% (offers $294 mln to acquire Aquarius Platinum Limited; Aquarius board intends to vote in favor of the offer), SWKS +1.8% (acquiring PMCS for $10.50/sh; also reported BTE Q4 guidance), LGF +1.1%
Select metals/mining stocks trading higher: CLF +6.1%, AU +2.7%, HMY +2.1%, GFI +2.1%, X +0.8%
Other news: NVCR +15.5% (receives FDA approval for Optune in Combination with Temozolomide in newly diagnosed glioblastoma patients), EXEL +8.8% (reports positive overall survival results from Phase 3 Trial of Cobimetinib in combination with Vemurafenib), RGLS +8.4% (to present additional preclinical data supporting RG-012 as novel microRNA therapeutic in development for Alport Syndrome at ASN's Kidney Week), ARNA +4.7% (announces that, at the request of the Board, Jack Lief, President and CEO, has retired from the company; Harry F. Hixson appointed interim CEO), ALKS +4.2% (FDA approved ARISTADA for the treatment of schizophrenia), AMDA +3.8% (files for ~29.53 mln share common stock offering by selling shareholders), RKUS +3.2% (to replace CYBX in the S&P SmallCap 600), WPRT +1.8% (co's joint venture Cummins Westport (CMI) announced the new ISL G Near Zero NOx natural gas engine), STM +1.7% (semi peer, in symp with PMCS), PBR +1.2% (adjusts its finnacing planning for 2015, 2016), CONN +0.9% (Director disclosed purchase of 12000 shares, worth total of $291K)
Analyst comments: NUVA +1.6% (upgraded to Outperform from Market Perform at BMO Capital), FDX +0.7% (upgraded to Buy from Hold at Stifel), CSAL +0.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley
)
In reaction to earnings/guidance: DD +6.3%, (issues guidance; Chair and CEO of DuPont, announced that she will retire from the company effective October 16), MNK +5.8%, SIMO +3.7%, PEP +2.6%
M&A news: PMCS +32.6% (PMC-Sierra to be acquired by Skyworks (SWKS) for $10.50 per share), STRZA +7.2% (LA Times reporting co and Lions Gate Entertainment (LGF) are in advanced merger talks), SBGL +5.5% (offers $294 mln to acquire Aquarius Platinum Limited; Aquarius board intends to vote in favor of the offer), SWKS +1.8% (acquiring PMCS for $10.50/sh; also reported BTE Q4 guidance), LGF +1.1%
Select metals/mining stocks trading higher: CLF +6.1%, AU +2.7%, HMY +2.1%, GFI +2.1%, X +0.8%
Other news: NVCR +15.5% (receives FDA approval for Optune in Combination with Temozolomide in newly diagnosed glioblastoma patients), EXEL +8.8% (reports positive overall survival results from Phase 3 Trial of Cobimetinib in combination with Vemurafenib), RGLS +8.4% (to present additional preclinical data supporting RG-012 as novel microRNA therapeutic in development for Alport Syndrome at ASN's Kidney Week), ARNA +4.7% (announces that, at the request of the Board, Jack Lief, President and CEO, has retired from the company; Harry F. Hixson appointed interim CEO), ALKS +4.2% (FDA approved ARISTADA for the treatment of schizophrenia), AMDA +3.8% (files for ~29.53 mln share common stock offering by selling shareholders), RKUS +3.2% (to replace CYBX in the S&P SmallCap 600), WPRT +1.8% (co's joint venture Cummins Westport (CMI) announced the new ISL G Near Zero NOx natural gas engine), STM +1.7% (semi peer, in symp with PMCS), PBR +1.2% (adjusts its finnacing planning for 2015, 2016), CONN +0.9% (Director disclosed purchase of 12000 shares, worth total of $291K)
Analyst comments: NUVA +1.6% (upgraded to Outperform from Market Perform at BMO Capital), FDX +0.7% (upgraded to Buy from Hold at Stifel), CSAL +0.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley
)